The Current Ratio as of December 2024 (TTM) for Unity Biotechnology, Inc. (UBX) is 3.45

According to Unity Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.45. This represents a change of -25.25% compared to the average of 4.61 of the last 4 quarters.

Unity Biotechnology, Inc. (UBX) Historical Current Ratio (quarterly & annually)

How has UBX Current Ratio performed in the past?

The mean historical Current Ratio of Unity Biotechnology, Inc. over the last ten years is 9.72. The current 3.45 Current Ratio has changed 3.44% with respect to the historical average. Over the past ten years (40 quarters), UBX's Current Ratio was at its highest in in the June 2018 quarter at 19.95. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Unity Biotechnology, Inc. (UBX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Unity Biotechnology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Unity Biotechnology, Inc. (UBX) Average Current Ratio

How has UBX Current Ratio performed in the past?

The current Current Ratio of Unity Biotechnology, Inc. (UBX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Unity Biotechnology, Inc. (UBX) Current Ratio vs. Peers

How is UBX’s Current Ratio compared to its peers?

Unity Biotechnology, Inc.’s Current Ratio is less than Exscientia plc (4.54), less than Recursion Pharmaceuticals, Inc. (4.35), less than Atea Pharmaceuticals, Inc. (19.33), less than Icosavax, Inc. (18.06), greater than HOOKIPA Pharma Inc. (3.26), less than Acumen Pharmaceuticals, Inc. (10.43), greater than Heron Therapeutics, Inc. (2.28), less than Homology Medicines, Inc. (4.19), less than Avidity Biosciences, Inc. (17.76), less than Beam Therapeutics Inc. (5.69), less than Intellia Therapeutics, Inc. (6.73), less than Editas Medicine, Inc. (3.75), less than Verve Therapeutics, Inc. (13.05), less than Prime Medicine, Inc. (6.50), greater than Windtree Therapeutics, Inc. (0.27), greater than Dermata Therapeutics, Inc. (3.44), greater than Ensysce Biosciences, Inc. (3.24), greater than Panbela Therapeutics, Inc. (0.26), less than Baudax Bio, Inc. (0), less than Neoleukin Therapeutics, Inc. (15.33), less than Nuvation Bio Inc. (9.57), less than Ovid Therapeutics Inc. (5.66), less than NextCure, Inc. (9.07), less than Connect Biopharma Holdings Limited (12.04),

Build a custom stock screener for Unity Biotechnology, Inc. (UBX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Unity Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Unity Biotechnology, Inc. (UBX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Unity Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.